Optimized HF Meds May Lessen MR Severity, Avoid Invasive Therapy Optimized HF Meds May Lessen MR Severity, Avoid Invasive Therapy

Patients with heart failure and mitral regurgitation should get at least 6 months of optimized guideline-directed medical therapy before invasive mitral repair is considered, researchers say.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news